ACHIEVE LIFE SCIENCES, INC. Insider Trading for May 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHIEVE LIFE SCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACHIEVE LIFE SCIENCES, INC. for May 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Buy | M | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Buy | M | 0.00 | 2,500 | 0 | 8,000 | 5.5 K to 8 K (+45.45 %) |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Buy | M | 0.00 | 5,000 | 0 | 12,500 | 7.5 K to 12.5 K (+66.67 %) |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 0.00 | 2,500 | 0 | 14,562 | 12.1 K to 14.6 K (+20.73 %) |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Buy | M | 0.00 | 2,500 | 0 | 7,000 | 4.5 K to 7 K (+55.56 %) |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 1.86 | 37,500 | 69,750 | 37,500 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 18,750 | 0 | 18,750 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 3,125 | 0 | 9,375 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,875 | 0 | 1,875 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Sell | S | 1.88 | 2,092 | 3,933 | 61,327 | 63.4 K to 61.3 K (-3.30 %) |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 7,500 | 0 | 63,419 | 55.9 K to 63.4 K (+13.41 %) |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.00 | 37,500 | 0 | 37,500 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 1.86 | 75,000 | 139,500 | 75,000 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 9,375 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 4,687 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 1.88 | 7,543 | 14,181 | 107,138 | 114.7 K to 107.1 K (-6.58 %) |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 15,624 | 0 | 114,681 | 99.1 K to 114.7 K (+15.77 %) |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | A | 1.86 | 25,000 | 46,500 | 25,000 | |
May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 |